Adults 18 to 35, any sex, with Ultrasound Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Heating Rate at 1 cm DepthPrimary· Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)
A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.
Group
Value
95% CI
Therapeutic Ultrasound Treatment
6.49
± 1.24
Heating Rate at 1.75 cm DepthPrimary· Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 8 minutes)
A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.
Group
Value
95% CI
Therapeutic Ultrasound Treatment
5.50
± 1.34
Heating Rate at 2.5 cm DepthPrimary· Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which did not occur in the 15 minute treatment)
A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.
Group
Value
95% CI
Therapeutic Ultrasound Treatment
3.07
± 1.53
Sponsor's own description
The purpose of this study is to determine the rate of tissue temperature increase in the triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment time. Thermocouples will be inserted at 1.0, 1.75, and 2.5 cm depths to determine the heating rates. Most modality textbook recommendations for therapeutic ultrasound are based on studies performed with the Omnisound ultrasound machine. Previous research has shown variations in power output across manufacturers, producing differences in tissue temperature increases. No information has been published regarding the heating rates of the Chattanooga Intelect Legend XT machine for ultrasound treatments. By determining the heating rates for this machine, clinicians will be better able to utilize the Chattanooga Intelect Legend XT to help reach therapeutic goals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by North Dakota State University
Last refreshed: 27 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03816709.